University of California, Los Angeles
Dr. Jonathan Goldman's research is focused on cancer drug development and on treatment for thoracic malignancies. In the UCLA Oncology Division, as part of the Jonsson Comprehensive Cancer Center, he is the Director of Clinical Trials in Thoracic Oncology and the Associate Director of Drug Development. His recent focus has been on the neoadjuvant and adjuvant use of targeted therapies, antibody drug conjugates, and immunotherapy combination. Clinically, he cares for patients with many types of cancer, and he has a particular focus on treating lung cancer. In collaboration with other departments, Dr. Goldman has also developed novel laboratory and radiographic techniques.
Session 2: Targeting EGFR Exon-20 Insertion Mutations in Non-Small Cell Lung Cancer
Wednesday, November 29, 2023
9:15 AM – 9:50 AM ET
Wednesday, November 29, 2023
9:50 AM – 10:00 AM ET